Lipid News

Crystal building blocks of triglycerides

Michael Airola
By Michael Airola
Dec. 1, 2019

Francis Crick once said, “If you want to understand function, study structure.” Do you agree? I certainly do, and I would argue that most lipid biologists do too. Just consider the effort to define chemical structures for the many thousands of lipids that exist and the hypotheses about individual lipid function that this structural information has generated.

What has lagged behind is the characterization of the structures of the proteins that modify, transport or interact with these lipids, but times are changing. For example, when I started my postdoc in Yusuf Hannun’s lab, only a handful of sphingolipid-metabolizing enzymes had been structurally characterized, and these were mainly from bacteria. While many questions remain open (hey, ceramide synthase — we can’t wait to see what you look like!), work from several labs has defined the structures and mechanisms for many human enzymes in sphingolipid metabolism.

A similar revolution appears to be happening with triglycerides. As most of you know, triglycerides serve as a reservoir for energy storage, but when they accumulate excessively, they can cause health problems, including obesity, diabetes and heart disease. Three new structures in particular have caught my attention.

Chrystal structureBeautiful structures of proteins involved in triglyceride metabolism and storage.Michael AirolaThe most recent is a crystal structure of microsomal triglyceride transfer protein complex, which transfers neutral lipids into apolipoprotein B-containing lipoproteins. The arduous crystallography required to conduct this work is impressive. The researchers revealed an unexpected lipid-binding cavity and provided insight into disease mutations as well as pharmacological inhibition of this therapeutic target.

The second is the crystal structure of lipoprotein lipase, or LPL, the major lipase that clears triglycerides in the blood. Gabriel Birrane and colleagues and Risha Arora and colleagues separately determined the LPL structures, overcoming the relative instability of LPL by complexing it with its binding partner glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1. These structures, along with other biochemical data, suggest LPL is active as a monomer, challenging the long-standing paradigm that LPL was only active as a dimer.

The last notable structure is that of seipin, a homo-oligomeric integral membrane protein that is a key player in the formation of cytoplasmic lipid droplets. Two groups (Renhong Yan and colleagues and Xuewu Sui and colleagues), using cryo-electron microscopy, found that 11 or 12 seipin molecules (dependent on the species) come together to form a ring that spans the endoplasmic reticulum membrane, can bind phosphatidic acid and may stabilize the formation of nascent lipid droplets.

What’s next? Who knows, but I’m darn sure we’re all gonna love it.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Michael Airola
Michael Airola

Michael Airola is an assistant professor of biochemistry and cell biology at Stony Brook University.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.